<?xml version='1.0' encoding='utf-8'?>
<regulation prefix="Regulation" num=".02" citation="COMAR 10.34.17.02" title_num="10" subtitle_num="34" chapter_num="17" heading="Pharmaceutical Specialty.">
  <paragraph num="A.">
    <text>The Board may recognize as a pharmaceutical specialty not listed under Regulation .01B(4) of this chapter, upon written application and supporting documentation to the Board by an applicant for a waiver permit.</text>
  </paragraph>
  <paragraph num="B.">
    <text>When evaluating an application for a waiver pharmacy, the Board shall consider whether:</text>
    <paragraph num="(1)">
      <text>The pharmaceutical specialty service is necessary to meet a specific therapeutic need;</text>
    </paragraph>
    <paragraph num="(2)">
      <text>The location is accessible without endangering public health and safety;</text>
    </paragraph>
    <paragraph num="(3)">
      <text>The pharmacy is properly equipped to perform the pharmaceutical specialty;</text>
    </paragraph>
    <paragraph num="(4)">
      <text>The applicant has provided a full and detailed description of the pharmaceutical specialty that clearly substantiates the basis for the request of a waiver permit; and</text>
    </paragraph>
    <paragraph num="(5)">
      <text>A policy and procedure manual is included with the application which sets forth a detailed description of the pharmacy operation.</text>
    </paragraph>
  </paragraph>
  <paragraph num="C.">
    <text>No one criterion or combination of criteria listed in §B of this regulation shall be binding upon the Board.</text>
  </paragraph>
  <paragraph num="D.">
    <text>The Board's determination of whether a limited practice or setting constitutes a pharmaceutical specialty is final.</text>
  </paragraph>
</regulation>